IAN Funded Clinical Research Co. Karmic Lifesciences Acquired By Cliantha Research

Started in 2005, Karmic Lifesciences has executed 150+ Clinical Trials and 75+ Clinical Data Management & Bio-Statistics Projects (Phase I to IV) in various therapeutic areas
Total
0
Shares

Cliantha Research, Ahmedabad headquartered global lifesciences company has acquired Karmic Lifesciences, Contract Research Organization headquartered in Mumbai, India.karmic-logo

Started in 2005, Karmic Lifesciences has executed 150+ Clinical Trials and 75+ Clinical Data Management & Bio-Statistics Projects (Phase I to IV) in various therapeutic areas including Oncology, Cardiovascular, Diabetes, Neurology, Auto-Immune Diseases, Ophthalmology, and Medical Devices. Karmic recently has successfully launched medico-marketing services for the pharmaceutical industry.

Karmic Lifesciences has developed kTrials™, a proprietary 21 CFR Part 11, CDASH/CDISC and SDTM Compliant, Web-Enabled eClinical Suite with integrated Clinical Trial Management, Clinical Data Management, eTMF, IWRS, SDTM Mapping, Clinical Data Warehousing and Operational Analytics functionalities designed especially to support Karmic’s end-to-end Global Clinical Operations, Data Management and Project Management requirements.

The system supports end-to-end operational activities right from project set-up, planning, budgeting, execution, performance analytics and reporting for all clinical trials conducted by Karmic apart from storing all clinical and operational enterprise data as well as electronic trial master files in a single repository.

#ShortNews: News you could use, useful data and actionable insights in a crisp and easy format. (Feedback:team@nextbigwhat.com)

Leave a Reply

Sign Up to Newsletter

Daily.

You May Also Like

Expedia Disposes Stake In Chinese Subsidiary eLong For $671 Million

The move was most likely instigated by eLong’s failure to turn a profit and the company also registered a $31 million loss in Q1 2015. The stake was snapped up by numerous Chinese travel firms, including Ctrip which confirmed that it paid about $400 mn for 37.6% stake. In order to make up for the lack of a partner in China, Expedia has announced that it will partner with Ctrip.
View Post